EON: Enhanced Online News (press release) SCHAUMBURG, Ill.--(EON: Enhanced Online News)--APP Pharmaceuticals, Inc., (APP) announced today that it has issued a voluntary recall of five lots of Irinotecan Hydrochloride Injection, which is used for recurrent or progressive metastatic colorectal ...
Huffington Post She tried a drug called gemcitabine , but the cancer did not respond. Her doctor, Steven Cohen, added Abraxane to the regimen, but whatever minimal response was seen was gone within three months. Finally, in early 2013, she tried cabazitaxel (Jevtana), ...
Healio ... obtained archival baseline specimens from patients enrolled in two Eastern Cooperative Oncology Group trials: E1395, a phase 3 trial that compared cisplatin plus paclitaxel with cisplatin plus 5-fluorouracil; and E3301, a phase 2 trial of docetaxel ...
The Oncology Report CHICAGO – The combination of bevacizumab and irinotecan far outshone tenozolomide in delaying disease progression among patients with MGMT-unmethylated glioblastoma, an investigator reported at the annual meeting of the American Society of ...
PharmiWeb.com (press release) The company pipeline includes two clinical stage products; CPX-351 (a liposomal formulation of cytarabine:daunorubicin) for the treatment of acute myeloid leukemia and CPX-1 (a liposomal formulation of irinotecan :floxuridine) for the treatment of ...
Benzinga ArQule Announces Phase 2 Study Results for Tivantinib in Combination with Cetuximab and Irinotecan for Colorectal Cancer at ASCO. Charles Gross, Benzinga Staff Writer. June 01, 2013 7:05 PM. + Follow. Print. Email. Tickers: ARQL · Benzinga Share: ...
The Oncology Report CHICAGO – The combination of bevacizumab and irinotecan far outshone tenozolomide in delaying disease progression among patients with MGMT-unmethylated glioblastoma, an investigator reported at the annual meeting of the American Society of ...
MarketWatch (press release) The company pipeline includes two clinical stage products; CPX-351 (a liposomal formulation of cytarabine:daunorubicin) for the treatment of acute myeloid leukemia and CPX-1 (a liposomal formulation of irinotecan :floxuridine) for the treatment of ... and more »
